Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1972 1
1973 7
1974 2
1975 4
1976 3
1977 3
1978 1
1979 8
1980 5
1981 6
1982 2
1983 6
1984 2
1985 3
1986 5
1987 4
1988 7
1989 2
1990 10
1991 6
1992 5
1993 7
1994 6
1995 3
1996 2
1997 4
1998 1
2000 5
2003 1
2004 2
2005 4
2006 3
2007 5
2008 6
2009 3
2010 2
2011 3
2012 7
2013 6
2014 5
2015 6
2016 7
2017 7
2018 9
2019 15
2020 14
2021 8
2022 2
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group. Muppidi S, et al. Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.
Priming: getting ready for battle.
Prime-A-Plant Group; Conrath U, Beckers GJ, Flors V, García-Agustín P, Jakab G, Mauch F, Newman MA, Pieterse CM, Poinssot B, Pozo MJ, Pugin A, Schaffrath U, Ton J, Wendehenne D, Zimmerli L, Mauch-Mani B. Prime-A-Plant Group, et al. Among authors: jakab g. Mol Plant Microbe Interact. 2006 Oct;19(10):1062-71. doi: 10.1094/MPMI-19-1062. Mol Plant Microbe Interact. 2006. PMID: 17022170 Free article. Review.
The effects of ozone on immune function.
Jakab GJ, Spannhake EW, Canning BJ, Kleeberger SR, Gilmour MI. Jakab GJ, et al. Environ Health Perspect. 1995 Mar;103 Suppl 2(Suppl 2):77-89. doi: 10.1289/ehp.95103s277. Environ Health Perspect. 1995. PMID: 7614952 Free PMC article. Review.
224 results